test

Ilko Menkov

@Vestal Point Capital, Lp

Latest period2024 - Q3ReportedManaged Assets$1.319BTotal holdings69
Assets growth rate-1.67%Assets growth rate (2-Q avg)4.62%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Vestal Point Capital, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 69 positions.

Assets under management

The assets under management (AUM) of Vestal Point Capital, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.319B in assets, with a quarterly growth rate of -1.67% and a 2-quarter average growth rate of 4.62%. The portfolio is managed by Ilko Menkov, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
GMEDGlobus Medical Inc
Recent Activity
Exited
0%
$61.641M
900,000 shares@ $68.49 avg price
BGNEBeigene Ltd
Recent Activity
Exited
0%
$49.934M
350,000 shares@ $142.67 avg price
EXASExact Sciences Corp
Recent Activity
Exited
0%
$39.081M
925,000 shares@ $42.25 avg price
AXSMAxsome Therapeutics Inc
Recent Activity
Exited
0%
$24.15M
300,000 shares@ $80.5 avg price
ALXOAlx Oncology Holdings Inc
Recent Activity
Exited
0%
$21.708M
3.6M shares@ $6.03 avg price
PRAXPraxis Precision Medicines Inc
Recent Activity
Exited
0%
$18.198M
440,000 shares@ $41.36 avg price
APLSApellis Pharmaceuticals Inc
Recent Activity
Exited
0%
$12.851M
335,000 shares@ $38.36 avg price
IMNMImmunome Inc
Recent Activity
Exited
0%
$12.1M
1M shares@ $12.1 avg price
DNLIDenali Therapeutics Inc
Recent Activity
Exited
0%
$11.61M
500,000 shares@ $23.22 avg price
BNTXBiontech Se
Recent Activity
Exited
0%
$8.036M
100,000 shares@ $80.36 avg price